Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-22 14:17:42 UTC |
---|
Update Date | 2021-09-14 15:46:08 UTC |
---|
HMDB ID | HMDB0002224 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Methyldeoxycytidine |
---|
Description | 5-Methyldeoxycytidine is a dinucleotide. Methylation of cytosine-guanine dinucleotide sequences (CpG dinucleotides) catalyzed by DNA methyltransferase, particularly in the 5′-promoter regions of mammalian genes, forms 5-methyldeoxycytidine (5-mdc) whose levels may regulate gene expression. Levels of 5-mdc and the expression of nm23-H1 (an anti-metastatic gene identified in and human cancer lines) are highly correlated with human hepatoma cells with different invasion activities. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. The levels of 5-mdc in the urine of patients with breast cancer is not significantly different than controls. (PMID: 17044778 , 17264127 , 16799933 ). |
---|
Structure | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6?,7-,8-/m1/s1 |
---|
Synonyms | Value | Source |
---|
2'-Deoxy-5-methylcytidine | HMDB | 5-Methyl-2'-deoxycytidine | HMDB | 5-Methyldeoxycytidine | MeSH |
|
---|
Chemical Formula | C10H15N3O4 |
---|
Average Molecular Weight | 241.2438 |
---|
Monoisotopic Molecular Weight | 241.106255983 |
---|
IUPAC Name | 4-amino-1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one |
---|
Traditional Name | 4-amino-1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one |
---|
CAS Registry Number | 838-07-3 |
---|
SMILES | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N |
---|
InChI Identifier | InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6?,7-,8-/m1/s1 |
---|
InChI Key | LUCHPKXVUGJYGU-SPDVFEMOSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrimidine nucleosides |
---|
Sub Class | Pyrimidine 2'-deoxyribonucleosides |
---|
Direct Parent | Pyrimidine 2'-deoxyribonucleosides |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidine 2'-deoxyribonucleoside
- Aminopyrimidine
- Pyrimidone
- Hydropyrimidine
- Pyrimidine
- Imidolactam
- Heteroaromatic compound
- Tetrahydrofuran
- Secondary alcohol
- Azacycle
- Oxacycle
- Organoheterocyclic compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Primary amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Methyldeoxycytidine,1TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N | 2372.6 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,1TMS,isomer #2 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N | 2370.9 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,1TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C | 2447.6 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N | 2359.3 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C | 2423.7 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2416.2 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TMS,isomer #4 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2403.0 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2389.1 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 2439.6 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C | 3063.2 | Standard polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2402.4 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2558.8 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 3040.8 | Standard polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2409.1 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2542.8 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2964.9 | Standard polar | 33892256 | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2412.8 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2555.8 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,4TMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C)[Si](C)(C)C | 2732.7 | Standard polar | 33892256 | 5-Methyldeoxycytidine,1TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N | 2639.0 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,1TBDMS,isomer #2 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N | 2647.5 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,1TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2677.9 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N | 2835.7 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2862.6 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 2861.7 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,2TBDMS,isomer #4 | CC1=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2839.6 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3065.0 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3084.9 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N[Si](C)(C)C(C)(C)C | 3246.9 | Standard polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3071.5 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3176.5 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #2 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3196.8 | Standard polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3064.0 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3164.1 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,3TBDMS,isomer #3 | CC1=CN([C@H]2CC(O)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3161.7 | Standard polar | 33892256 | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3265.6 | Semi standard non polar | 33892256 | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3326.9 | Standard non polar | 33892256 | 5-Methyldeoxycytidine,4TBDMS,isomer #1 | CC1=CN([C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)C(=O)N=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3087.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9420000000-4af773e99af76af961ea | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (2 TMS) - 70eV, Positive | splash10-0006-9014000000-1fd11a88c9a0762a6b1d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Methyldeoxycytidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Positive-QTOF | splash10-004i-0900000000-d1d23649ec4fa9201eba | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Positive-QTOF | splash10-004i-2900000000-d21a1bb287e1d523b6c2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Positive-QTOF | splash10-004i-3900000000-b4f3cca0a164fdbc5031 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Negative-QTOF | splash10-0a4j-0920000000-6aa55dc948aac874e1a0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Negative-QTOF | splash10-0uk9-2920000000-6d51e08eb5820a748902 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Negative-QTOF | splash10-007p-9400000000-77fb64e0199129096777 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Negative-QTOF | splash10-00dl-0970000000-a011cf5a5c3613811717 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Negative-QTOF | splash10-00dl-9600000000-ee60e868c938ff348f09 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Negative-QTOF | splash10-006y-9500000000-81204e67016c197ad16f | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 10V, Positive-QTOF | splash10-004i-0900000000-a1c51dd1d9ae2dee6e38 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 20V, Positive-QTOF | splash10-00b9-2900000000-7c9c6f54bbfba0acc135 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Methyldeoxycytidine 40V, Positive-QTOF | splash10-0059-6900000000-9559671d86d852719546 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
---|
General References | - Cho SH, Jung BH, Lee SH, Lee WY, Kong G, Chung BC: Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2006 Nov;20(11):1229-36. [PubMed:16799933 ]
- Yang TH, Hu ML: Intracellular levels of S-adenosylhomocysteine but not homocysteine are highly correlated to the expression of nm23-H1 and the level of 5-methyldeoxycytidine in human hepatoma cells with different invasion activities. Nutr Cancer. 2006;55(2):224-31. [PubMed:17044778 ]
- Liu Z, Liu S, Xie Z, Blum W, Perrotti D, Paschka P, Klisovic R, Byrd J, Chan KK, Marcucci G: Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method. Nucleic Acids Res. 2007;35(5):e31. Epub 2007 Jan 30. [PubMed:17264127 ]
|
---|